Company / Shareholders' Equity
Xtant Medical Holdings, Inc. Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$43.0M
FY2025
5-year range
$14.5M / $51.3M
FY2021-FY2025
Trend
-16.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity has fluctuated over the past 10 years, ranging from -$59M in FY2018 to $51M in FY2024.
Based on SEC 10-K filings.
$43M in FY2025 with a 3-year CAGR of +11.6%.
Improved from $34M to $43M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +11.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +11.6%, indicating consistent growth.
- In FY2025, shareholders' equity decreased 16.3% year-over-year.
- Peak shareholders' equity was recorded in FY2024.
- Lowest shareholders' equity in the period was in FY2018.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $43.0M | -16.3% |
| FY2024 | $51.3M | +50.3% |
| FY2023 | $34.2M | +10.6% |
| FY2022 | $30.9M | +112.8% |
| FY2021 | $14.5M | +132.8% |
| FY2020 | -$44.2M | -1.0% |
| FY2019 | -$43.8M | +25.4% |
| FY2018 | -$58.7M | -729.9% |
| FY2017 | -$7.1M | -179.7% |
| FY2016 | $8.9M | +214.2% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026